$25.69
-0.16[-0.62%]
At close: Apr 30
$25.69
0[0.00%]
After Hours: 4:20PM EDT
Surmodics
(NASDAQ:SRDX)Latest News for Surmodics Stock (NASDAQ:SRDX)
Surmodics Stock (NASDAQ: SRDX)
Categories: All
Wednesday, April 10, 2024
Thursday, February 01, 2024
- Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Feb 1, 2024, 1:17PM
- Needham Maintains Buy on Surmodics, Raises Price Target to $47Benzinga Newsdesk - Feb 1, 2024, 12:54PM
- Surmodics shares are trading lower after the company reported Q1 financial results and issued FY23 guidance.Benzinga Newsdesk - Feb 1, 2024, 12:49PM
- Surmodics Expects FY24 Adjusted EPS Loss Of $(1.17)-$(0.87) Compared To The Prior Guidance Of $(1.32)-$(0.97) And Consensus Of $(1.16)Benzinga Newsdesk - Feb 1, 2024, 7:15AM
- Surmodics Expects FY24 Sales Of $117M-$121M, And $113M-$117M, Excluding SurVeil DCB License Fee Revenue, Compared To The Prior Guidance Of $116M-$121M, And $112M-$117M, Respectively, And The Consensus Of $119.26MBenzinga Newsdesk - Feb 1, 2024, 7:13AM
- Surmodics Q1 Adjusted EPS $0.00 May Not Be Comparable To $(0.30) Estimate, Sales $30.55M Beat $29.64M EstimateBenzinga Newsdesk - Feb 1, 2024, 7:02AM
- Earnings Scheduled For February 1, 2024Benzinga Insights - Feb 1, 2024, 5:03AM
Wednesday, January 31, 2024
Monday, January 22, 2024
Thursday, November 16, 2023
- Surmodics Announced 24-month Data From The Swing Trial, A First-in-human Study Of The Safety And Performance Of Sundance Sirolimus Drug-Coated Balloon (DCB) At 50th annual VEITH Symposium In New YorkBenzinga Newsdesk - Nov 16, 2023, 7:42AM
- Surmodics Announced The presentation Of 36-month Data From Its Transcend Clinical Trial By Dr. Peter A. Schneider At The 50th Annual Veith Symposium In New York, New YorkBenzinga Newsdesk - Nov 16, 2023, 7:31AM
Thursday, November 09, 2023
Wednesday, November 08, 2023
- Needham Maintains Buy on Surmodics, Lowers Price Target to $44Benzinga Newsdesk - Nov 8, 2023, 5:10PM
- Surmodics Sees FY24 Non-GAAP Diluted Loss Per Share To Range From $(1.32)-$(0.97) Vs. $(1.24) EstimateBenzinga Newsdesk - Nov 8, 2023, 7:29AM
- Surmodics Expects FY24 Total Revenue To Range From $116M-$121M Vs. $115.52M Estimate, Representing Decrease Of (13)%-(9)% Compared To FY23Benzinga Newsdesk - Nov 8, 2023, 7:26AM
- Surmodics Q4 Adj. EPS $0.53 Compared To $(0.26) In The Prior-Year Period, Sales $27.97M Beat $26.27M EstimateBenzinga Newsdesk - Nov 8, 2023, 7:21AM
- Earnings Scheduled For November 8, 2023Benzinga Insights - Nov 8, 2023, 4:21AM
Wednesday, August 02, 2023
- Needham Reiterates Buy on Surmodics, Raises Price Target to $50Benzinga Newsdesk - Aug 2, 2023, 12:20PM
- Earnings Scheduled For August 2, 2023Benzinga Insights - Aug 2, 2023, 8:45AM
- Surmodics shares are trading higher after the company reported better-than-expected Q3 results.Benzinga Newsdesk - Aug 2, 2023, 8:20AM
- Surmodics, Inc Expects FY23 Revenue $130M-$132M (Prior $103M-$106M) Vs $116.95M Est, Adj EPS Loss $(0.29)-$(0.14) (Prior $(1.98)-$(1.68)) Vs $(1.3) EstBenzinga Newsdesk - Aug 2, 2023, 7:24AM
- Surmodics Q3 EPS $0.52 May Not Be Comparable To $(0.46) Estimate, Sales $52.48M Beat $26.70M EstimateBenzinga Newsdesk - Aug 2, 2023, 7:19AM
Wednesday, June 21, 2023
Tuesday, June 20, 2023
- Why Surgalign Holdings Shares Are Trading Lower By Around 75%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Jun 20, 2023, 1:07PM
- Surmodics shares are trading higher after the company announced it received FDA approval for the SurVeil drug-coated balloon.Benzinga Newsdesk - Jun 20, 2023, 11:31AM
- Needham Reiterates Buy on Surmodics, Maintains $36 Price TargetBenzinga Newsdesk - Jun 20, 2023, 10:37AM
- DICE Therapeutics, Surmodics, Nikola, And Other Big Stocks Moving Higher On TuesdayLisa Levin - Jun 20, 2023, 10:22AM
- After FDA Rejection, Surmodics' SurVeil Drug-Coated Balloon Scores FDA ApprovalVandana Singh - Jun 20, 2023, 9:54AM
- Surmodics Receives FDA Approval For SurVeil Drug-Coated BalloonBenzinga Newsdesk - Jun 20, 2023, 6:34AM
Tuesday, June 13, 2023
- Second Time May Be a Charm: Analyst Is Bullish As Surmodics Resubmits SurVeil DCB ApplicationVandana Singh - Jun 13, 2023, 2:40PM
- Why Motorcar Parts of America Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Jun 13, 2023, 12:47PM
- Surmodics shares are trading higher after Needham upgraded the stock from Hold to Buy and announced a $36 price target.Benzinga Newsdesk - Jun 13, 2023, 11:54AM
- Benzinga's Top Ratings Upgrades, Downgrades For June 13, 2023Benzinga Insights - Jun 13, 2023, 11:00AM
- Needham Upgrades Surmodics to Buy, Announces $36 Price TargetBenzinga Newsdesk - Jun 13, 2023, 5:35AM
Friday, May 26, 2023
Friday, April 28, 2023
Wednesday, April 26, 2023
- Earnings Scheduled For April 26, 2023Benzinga Insights - Apr 26, 2023, 7:13AM
- Surmodics Expects FY23 Sales Of $103M-$106M Vs. $102M-$106M Expected Earlier, Compared To Consensus Of $104.84M; Reaffirms FY23 Adjusted EPS Guidance Of $(2.09)-$(1.69) Vs. Consensus Of $(2.38)Benzinga Newsdesk - Apr 26, 2023, 7:12AM
- Surmodics Q2 Adjusted EPS $(0.40) Beats $(0.48) Estimate, Sales $27.20M Beat $25.86M EstimateBenzinga Newsdesk - Apr 26, 2023, 7:02AM